We use cookies to improve your experience on this website. Read More Allow Cookies

Latest News From BioPharmaChem

    February 2013

  • Diclofenac used and recommended globally, despite cardiovascular risks

    13 February, 2013

    A study in this week's PLOS Medicine finds that the painkiller diclofenac (a non-steroidal anti-inflammatory drug (NSAID) in the same class as aspirin) is the most commonly used NSAID in the 15 countries studied and is included in the essential medicines lists of 74 low-, middle- and high-income countries, despite its known tendency to cause heart attacks and strokes in vulnerable patients.

    Continue Reading »